Catalyst Wire Dossier Catalyst Wire Dossier

Terbinafine (Lamisil)

Terbinafine · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Terbinafine (Lamisil), covering 2025-02-07 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients [Phase 1, Phase 2]

See pricing